Properties

This section outlines the chemical and physical properties of key drug classes monitored in TDM

General Overview of Chemical and Physical Properties in TDM

  • Importance: Understanding the chemical and physical properties of drugs is critical for comprehending their ADME processes, mechanism of action, analytical methods, and TDM
  • Properties Influencing ADME
    • Solubility: Affects absorption and excretion
    • Ionization: Impacts absorption, distribution, and renal excretion
    • Protein Binding: Influences distribution and free drug concentration
    • Partition Coefficient (Log P): Affects membrane permeability and distribution

Drug Classes and Properties

Aminoglycosides (e.g., Gentamicin)

  • Definition: Antibiotics used to treat bacterial infections
  • Chemical Structure: Amino-modified glycosides (sugars)
  • Molecular Weight: 400-600 Da
  • Solubility: Highly water-soluble due to multiple polar amino and hydroxyl groups
  • Ionization: Polycationic at physiological pH
  • Protein Binding: Low protein binding (< 30%)
  • Pharmacokinetic Implications: Poor oral absorption, limited distribution, renal excretion
  • Analytical Methods: Immunoassays, chromatography, mass spectrometry

Cardioactive Drugs (e.g., Digoxin)

  • Definition: Used to treat heart failure and arrhythmias
  • Chemical Structure: Steroid nucleus linked to a lactone ring and sugar molecules
  • Molecular Weight: Approximately 780 g/mol
  • Solubility: Slightly soluble in water
  • Ionization: Variable, depends on functional groups
  • Protein Binding: Moderate protein binding (20-30%)
  • Pharmacokinetic Implications: Oral bioavailability varies, distributes widely, renal excretion
  • Analytical Methods: Immunoassays, chromatography

Anticonvulsants (e.g., Phenobarbital)

  • Definition: Used to prevent or control seizures
  • Chemical Structure: Barbiturate
  • Molecular Weight: Approximately 232 g/mol
  • Solubility: Slightly soluble in water
  • Ionization: Weakly acidic
  • Protein Binding: Moderate protein binding (45-60%)
  • Pharmacokinetic Implications: Oral bioavailability, extensive metabolism in the liver, renal excretion (pH-dependent)
  • Analytical Methods: Immunoassays, chromatography

Antidepressants (e.g., Lithium)

  • Definition: Used to treat depression and mood disorders
  • Chemical Structure: Simplest structure in the antidepressents, with only a single charge
  • Molecular Weight: Approximately 7 g/mol
  • Solubility: Lithium salts soluble in water
  • Ionization: Exists as a monovalent cation (\(Li^+\)) in solution
  • Protein Binding: Negligible protein binding
  • Pharmacokinetic Implications: Rapid and complete oral absorption, distributes throughout total body water, renal excretion
  • Analytical Methods: Flame Emission Spectrophotometry (FES), Ion-Selective Electrode (ISE), Atomic Absorption Spectrometry (AAS)

Immunosuppressants (e.g., Tacrolimus)

  • Definition: Used to prevent organ rejection and treat autoimmune diseases
  • Chemical Structure: Macrolide lactone
  • Molecular Weight: Approximately 804 g/mol
  • Solubility: Practically insoluble in water
  • Ionization: Not applicable
  • Protein Binding: Highly protein-bound (approximately 99%)
  • Pharmacokinetic Implications: Low and variable oral bioavailability, extensive metabolism in the liver, biliary excretion
  • Analytical Methods: Immunoassays, chromatography (LC-MS/MS)

Summary Table of Chemical and Physical Properties

Drug Class Solubility Ionization Protein Binding Key Chemical Features
Aminoglycosides Water Polycationic Low Amino sugars, glycosidic bonds
Cardioactive Drugs Variable Variable Moderate Steroid nucleus, lactone ring, sugar
Anticonvulsants Slightly Soluble Weakly Acidic Moderate Barbituric acid ring
Antidepressants Water Monovalent Cation Negligible Single positive charge
Immunosuppressants Insoluble N/A High Macrolide lactone

Clinical Significance

  • These properties influence how the drug is absorbed, distributed, metabolized, and excreted (ADME)
  • Affects the choice of analytical method
  • Knowledge of how drug properties can change due to disease states, concomitant disease and drug interactions